封面
市场调查报告书
商品编码
1866494

空胶囊市场-2025-2030年预测

Empty Capsules Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计空胶囊市场将从 2025 年的 40.34 亿美元成长到 2030 年的 51.34 亿美元,复合年增长率为 4.94%。

全球空胶囊市场预计将迎来显着成长,主要受消费者不健康生活方式导致营养补充品需求不断增长的推动。这一趋势,加上胶囊製造技术的进步和研发投入的增加,预计将进一步促进市场扩张。此外,人口结构变化,例如人口老化和千禧世代健康意识的增强,以及蓬勃发展的体育产业和运动营养产品消费量的增长,也对市场起到了支撑作用。然而,印度等开发中国家的伦理问题以及医药产业的严格监管,对市场成长构成了挑战。

市场驱动因素

不断扩张的製药业

製药业的扩张是空胶囊市场的主要驱动力。慢性病盛行率的上升以及公共和私营部门研发投入的增加,推动了药物递送用胶囊的需求。特别是明胶基空胶囊,因其药物快速释放和抗氧化特性而备受青睐,是製药应用的关键组成部分。该产业对创新製剂研发的重视,进一步推动了对可靠胶囊解决方案的需求。

人口老化加剧

全球老龄人口的成长是推动空胶囊市场发展的关键因素。老年人更容易出现健康问题,从而带动了对胶囊形式的营养补充剂和药物的需求。此外,千禧世代日益增强的健康意识也促进了营养补充剂的消费,进一步推动了市场成长。体育产业的蓬勃发展以及运动营养产品需求的激增,也为迎合健康意识人群的胶囊生产商创造了机会。

市场限制

严格的政府法规

製药业的严格监管,尤其是在已开发市场,对空胶囊市场构成了挑战。满足严格的安全和品质标准会增加生产成本和复杂性,这可能会减缓市场成长。在印度等开发中国家,人们对胶囊材料(例如动物源性明胶)的伦理担忧可能会限制消费者的接受度,并阻碍市场扩张。

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

第五章空胶囊市场产品分析

  • 介绍
  • 明胶胶囊
  • 非明胶胶囊

第六章 依功能空胶囊市场

  • 介绍
  • 速效胶囊
  • 缓释性胶囊
  • 延迟释放胶囊

第七章 依最终用户空胶囊市场

  • 介绍
  • 营养保健品产业
  • 製药业
  • 化妆品产业
  • 研究所
  • 动物用药品业

第八章空胶囊市场(按地区划分)

  • 介绍
  • 北美洲
    • 副产品
    • 按功能
    • 最终用户
    • 按国家/地区
      • 美国
      • 加拿大
      • 墨西哥
  • 南美洲
    • 副产品
    • 按功能
    • 最终用户
    • 按国家/地区
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 副产品
    • 按功能
    • 最终用户
    • 按国家/地区
      • 英国
      • 德国
      • 法国
      • 西班牙
      • 其他的
  • 中东和非洲
    • 副产品
    • 按功能
    • 最终用户
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 副产品
    • 按功能
    • 最终用户
    • 按国家/地区
      • 中国
      • 日本
      • 印度
      • 韩国
      • 台湾
      • 其他的

第九章:竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十章:公司简介

  • Capsugel
  • ACG Worldwide
  • Qualicaps
  • Suheung Co., Ltd.
  • Bright Pharma Caps Inc.
  • Medi-Caps Ltd.
  • CapsCanada Corporation
  • Roxlor LLC
  • Snail Pharma Industry Co., Ltd.
  • HealthCaps India Ltd.

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061611733

The Empty Capsules Market is anticipated to increase from USD 4.034 billion in 2025 to USD 5.134 billion by 2030, with a 4.94% CAGR.

The global empty capsules market is poised for significant growth, driven by the rising demand for nutraceuticals spurred by unhealthy consumer lifestyles. This trend, coupled with technological advancements in capsule manufacturing and increased investments in research and development, is expected to propel market expansion. The market is further supported by demographic shifts, including an aging population and growing health consciousness among millennials, alongside the burgeoning sports industry and increased consumption of sports nutrition products. However, ethical concerns in developing countries like India and stringent regulations in the pharmaceutical sector pose challenges to market growth.

Market Drivers

Growing Pharmaceutical Industry

The pharmaceutical sector's expansion is a primary driver of the empty capsules market. The increasing prevalence of chronic diseases and heightened R&D investments by both public and private entities are boosting demand for capsules used in drug delivery. Empty capsules, particularly gelatin-based ones, are favored for their quick drug release and anti-oxidation properties, making them essential for pharmaceutical applications. The sector's focus on developing innovative formulations further amplifies the need for reliable capsule solutions.

Increasing Geriatric Population

The growing geriatric population globally is a significant factor fueling the empty capsules market. Older adults, more prone to health issues, are driving demand for nutraceuticals and medications delivered via capsules. Additionally, millennials' rising health consciousness is increasing the consumption of dietary supplements, further supporting market growth. The sports industry's growth, with a surge in demand for sports nutrition products, also creates opportunities for capsule manufacturers to cater to this health-focused demographic.

Market Restraints

Stringent Government Regulations

Stringent regulations in the pharmaceutical industry, particularly in developed markets, pose a challenge to the empty capsules market. Compliance with rigorous safety and quality standards increases production costs and complexity, potentially slowing market growth. In developing countries like India, ethical concerns related to capsule materials, such as gelatin derived from animal sources, may limit consumer acceptance and hinder market expansion.

Market Segmentation

The empty capsules market is segmented by product, end-user, and geography. By product, gelatin capsules are expected to dominate due to their rapid drug release and anti-oxidation properties, making them a preferred choice for pharmaceutical and nutraceutical applications. By end-user, the pharmaceutical sector is projected to grow significantly, driven by rising disease prevalence and R&D investments. The Asia-Pacific region is anticipated to lead geographically, fueled by increasing disposable incomes, rising health expenditures, and low-cost materials and labor, which attract major manufacturers to the region.

Key Players

Leading companies in the empty capsules market include Suheung Co Ltd., ACG Worldwide, Capsugel, Bright Pharma Caps Inc., Medi-Caps Ltd., Snail Pharma Industry Co., Ltd., Capscanada Corporation, Qualicaps, and Roxlor LLC. These players focus on product innovation, strategic partnerships, and capacity expansions to maintain competitive advantage.

Industry Outlook

The empty capsules market is set for robust growth, driven by the pharmaceutical and nutraceutical sectors' expansion, demographic trends, and technological advancements. While regulatory and ethical challenges persist, the market's potential in Asia-Pacific and its alignment with health-conscious consumer trends position it for sustained growth in the coming years.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

By Product

  • Gelatin Capsules
  • Non-Gelatin Capsules

By Function

  • Immediate Release Capsules
  • Sustained Release Capsules
  • Delayed Release Capsules

By End User

  • Nutraceuticals Industry
  • Pharmaceutical Industry
  • Cosmetics Industry
  • Research Laboratories
  • Animal Health Industry

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. EMPTY CAPSULES MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Gelatin Capsules
  • 5.3. Non-Gelatin Capsules

6. EMPTY CAPSULES MARKET BY FUNCTION

  • 6.1. Introduction
  • 6.2. Immediate Release Capsules
  • 6.3. Sustained Release Capsules
  • 6.4. Delayed Release Capsules

7. EMPTY CAPSULES MARKET BY END USER

  • 7.1. Introduction
  • 7.2. Nutraceuticals Industry
  • 7.3. Pharmaceutical Industry
  • 7.4. Cosmetics Industry
  • 7.5. Research Laboratories
  • 7.6. Animal Health Industry

8. EMPTY CAPSULES MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product
    • 8.2.2. By Function
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Product
    • 8.3.2. By Function
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Product
    • 8.4.2. By Function
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Product
    • 8.5.2. By Function
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Product
    • 8.6.2. By Function
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Capsugel
  • 10.2. ACG Worldwide
  • 10.3. Qualicaps
  • 10.4. Suheung Co., Ltd.
  • 10.5. Bright Pharma Caps Inc.
  • 10.6. Medi-Caps Ltd.
  • 10.7. CapsCanada Corporation
  • 10.8. Roxlor LLC
  • 10.9. Snail Pharma Industry Co., Ltd.
  • 10.10. HealthCaps India Ltd.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations